FindTrial
Sign In

Combined Subclavian vein and internal jugular vein collapsibility index as a predictor of hypotension after induction of General anaesthesia in Hypertensive patients: A prospective observational study.

Subclavian vein collapsibility combined with internal jugular vein collapsibility index as a predictor of hypotension after induction of general anaesthesia in hypertensive patients - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076669
Enrollment
160
Registered
2024-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: USG evaluation of Subclavian vein(SCV)and Internal Jugular Vein(IJV): In pre operative room- In Supine position, USG evaluation of SCV and IJV (spontaneously breathing) will be perform

Sponsors

AIIMS Gorakhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 60 years of either gender ASA class II History of controlled HTN with or without medications for more than 6months BMI less than 35kg/m2 undergoing elective non cardiac surgery

Exclusion criteria

Exclusion criteria: Patient refusal Congenital or valvular heart disease or implanted pacemakers or currents ACEIs or ARBs medications. History of CVA or peripheral vascular disease or chronic renal failure or DM or morbid obesity Lateral or prone positions procedure Emergency surgery

Design outcomes

Primary

MeasureTime frame
To assess the accuracy of combined subclavian vein collapsibility index and internal jugular vein collapsibility index in predicting post induction hypotension after induction of general anesthesia in hypertensive patients.Timepoint: 1min 2min 3min 4min 5min 6min 7min 8min 9min 10min 11min 12min 13min 14min 15min—

Secondary

MeasureTime frame
To know the incidence of hypertension varying in particular age group, sex or antihypertensive drugs usedTimepoint: At baseline—

Countries

India

Contacts

Public ContactDr Urvasie Salam

All India Institute of Medical Sciences , Gorakhpur

drvijeta86gsvm@gmail.com9918724600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026